Evidence map›Paper›PMID 42850434›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Differentiation of axial spondyloarthritis-related lesions from degenerative lesions on Na[

Jerney de Jongh, Sam Groothuizen, Gerben J C Zwezerijnen, Robert Hemke, Tom Doorschodt, Ralph Paul Maguire, Tom Vaux, Conny J van der Laken

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jerney de JonghDepartment of Rheumatology & Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands.
Sam GroothuizenDepartment of Rheumatology & Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands. s.groothuizen@amsterdamumc.nl.ORCID http://orcid.org/0009-0007-6097-8886
Gerben J C ZwezerijnenDepartment of Radiology & Nuclear Medicine, Amsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-9571-9362
Robert HemkeDepartment of Radiology & Nuclear Medicine, Amsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-0826-302X
Tom DoorschodtDepartment of Radiology & Nuclear Medicine, OLVG, Amsterdam, The Netherlands.
Ralph Paul MaguireUCB Biopharma SRL, Brussels, Belgium.ORCID http://orcid.org/0000-0003-3937-6622
Tom VauxUCB Pharma, Slough, United Kingdom.
Conny J van der LakenDepartment of Rheumatology & Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-9865-6213

Funding

UCB Pharma UCB Pharma
6 · The paper itself

Abstract

purposeTo investigate longitudinal changes of Na[

methods20 active r-axSpA patients were included. Na[

resultsA total of 276 lesions with visual Na[

conclusionNa[

Indexed as

Ankylosing spondylitisImagingNa[18F]FluoridePositron emission tomographyRadiographic axial spondyloarthritis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.